Press release
MedAware Systems Launches Comprehensive Dementia / Alzheimer’s Disease Research Database
MedAware Systems’ patent-pending software and process converts published clinical trials into the component data which can then be analyzed using standard statistical analytic techniques.
The database, as well as analytics, are available for licensing by Industry and researchers.
“For the first time, all of the raw data from human clinical trials in the area of Dementia are available in a single database”, says Founder and Chief Science Officer, Dr. Zung Vu Tran, a leading authority on bio-statistics. He adds “We have solved a myriad of problems in collecting, organizing, and standardizing this vast quantity of data. Companies and researchers will now have, at their fingertips, data from thousands of medical research studies on Alzheimer’s disease and other forms of dementia. This will save them years of effort in trying to collect, analyze and continuously update the available science in the field.”
ABOUT MEDAWARE SYSTEMS, INC.
MedAware Systems, Inc. disrupts the health informatics industry by forever changing the way Pharma and medical device companies, physicians, payers and consumers derive usable evidence from published clinical trials research. The Company’s Science of Health Informatics (SOHInfo™) is a Scientific-Data-as-a-Service (SDaaS™) that solves the problem of making the vast and chaotic body of human clinical trials research instantly available and indispensable for understanding the safety and efficacy of medical treatments and devices.
MedAware Systems, Inc.
3400 Industrial Ln. Suite 1B
Broomfield, CO 80020
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release MedAware Systems Launches Comprehensive Dementia / Alzheimer’s Disease Research Database here
News-ID: 859513 • Views: …
More Releases from MedAware Systems, Inc.
MedAware Systems Adds Sentiment Tracking for Social Media Event Reports
MedAware Systems announced today that it has added a new Sentiment Tracking feature to its Social Media Event Monitoring application for Medical Devices. This new feature offers valuable signaling intelligence for post market surveillance and reporting for MDR and FDA filings. The feature utilizes the Company's Advanced Intelligence™ capabilities to provide deeper insight into reported events and other related posts on Social Media.
Events are identified for specific devices and…
MedAware Systems Expands Neuromodulation Device Regulatory Data Portal
MedAware Systems announced today a major expansion of Neuromodulation device data in its SOHInfo (www.sohinfo.com) customer portal. The portal is populated with reported data from registries, published literature, and social media for all registered devices for Spinal Cord Stimulation, Peripheral Nerve Stimulation, Ganglia Dorsal Root Stimulation, RF Ablation, Parkinson - Deep Brain Stimulation, Sacral Stimulation – Incontinence, and others. Global regulatory reported data is provided on all manufacturers’ products for…
MedAware Systems Launches AI-Powered Post Market Surveillance for Catheter Intro …
MedAware Systems announces that its Science of Health Informatics (SOHInfo) Post Market Surveillance Service for Catheter Introducer devices is now available.
SOHInfo monitors government regulatory adverse event databases, published literature, and social media to provide complete monitoring of the devices from all major manufacturers, including Steris Corporation, Sotera Health, Abbott, Cardinal Health, Merit Medical, Cordis Corporation, Terumo, Cook Medical, Teleflex, Medtronic, C.R. Bard, and others.
The surveillance system supports both…
MedAware Systems Adds Social Media to its Medical Device Surveillance Service
MedAware Systems’ Science of Health Informatics (SOHInfo) announces a major upgrade of its medical device surveillance service to include reporting on social media posts.
SOHInfo monitors government regulatory adverse event databases as well as relevant data from the published literature. It now includes social media surveillance to provide complete monitoring of clients’ products. The platform offers comprehensive visibility and active alerts across all three major platforms, LinkedIn, Facebook, and Twitter.…
More Releases for Dementia
Dementia Care APP Market Is Booming Worldwide 2021-2027 | Dementia Digital Diary …
Global Dementia Care APP market 2020-2026 in-depth study accumulated to supply latest insights concerning acute options. The report contains different predictions associated with Dementia Care APP market size, revenue, production, CAGR, consumption, profit margin, price, and different substantial factors. Whereas accentuation the key driving and Dementia Care APP restraining forces for this market, the report offers trends and developments. It additionally examines the role of the leading…
Dementia screening and prevention – hope or hype?
It is estimated that about 50% of dementia patients do not receive a formal diagnosis. And when the diagnosis is made, it often happens at a time when the disease is well advanced and brain damages are irreversible.
A major reason for this is that systematic dementia screening and prevention programmes are not yet ready for implementation as large-scale public health interventions. A key reason for this is the desire…
Dementia Treatment
Dementia Drugs and Treatment Market describes its growth, size, share, Forecast and trends to 2025
The global Dementia Drugs and Treatment market is valued at 13900 million US$ in 2018 is expected to reach 26500 million US$ by the end of 2025, growing at a CAGR of 8.4% during 2019-2025.
This report focuses on Dementia Drugs volume and value at global level, regional level and company level. From a global perspective, this…
New App detects dementia risks early
• The App is certified as a Medical Device.
• Early stages are reliably detected, before the brain damage becomes irreversible.
• Sensitivity above 96%, significantly higher than with the established tests (e.g., MMSE 71%).
• Now available for free during pre-launch.
Dementia is a rapidly increasing social problem of a rapidly aging society. Because until today there is no effective therapy for advanced stages of dementia.
Therefore, effective screening tests are needed to detect early stages…
2nd International Conference on Dementia and Dementia Care
Breakthrough in Dementia Research and Care
Event Name: 2nd International Conference on Dementia and Dementia Care (Dementia 2019)
Theme: Breakthrough in Dementia Research and Care
Aim and Scope: Dementia is an umbrella term used to describe a set of symptoms that occur when the brain is affected by disease. There’s currently no cure and no treatment that slows or stops its progression, but there are things you can do to help reduce the…
11th International Conference on Vascular Dementia
Can We Cure Dementia, Vascular Dementia and Alzheimer's disease?
It’s our pleasure to invite all the participants from all over the world to attend the 11th International Conference on Vascular Dementia which is held during February 15-16, 2019 Amsterdam| Netherlands.
Vascular Dementia conference will assemble illustrious speakers, Researchers, Nobel laureates, Neurologists, and Neuroscience researchers from both academic and health care professionals will join this event to discuss their views and research. The…
